Drug Companies Breathe Easier As PDUFA VI Heads for Approval.
نویسنده
چکیده
Drug companies breathe easier as PDUFA VI heads for approval.
منابع مشابه
Does $760 m a year of industry funding affect the FDA's drug approval process?
In 1992, because of widespread concern that the US Food and Drug Administration was taking too long to approve drugs, the Prescription Drug User Fee Act (PDUFA) was enacted, authorizing the FDA to collect user fees from drug companies to expedite the approval process. Besides providing funding for an increased FDA staff, the act established performance goals during the approval process to ensur...
متن کاملDrug-review deadlines and safety problems.
BACKGROUND The Prescription Drug User Fee Act (PDUFA) imposes deadlines for the completion of drug reviews by the Food and Drug Administration (FDA). Critics have suggested that these deadlines may result in rushed approvals and the emergence of unanticipated safety problems once a product is in clinical use. METHODS We assessed the association between the PDUFA deadlines and the timing of FD...
متن کاملPharmacy Groups Want to Change The FDA's REMS Authority: Battles Loom as Congress Aims to Pass a Major Bill by September 2012.
ify higher fees for drug companies; however, revamping REMS won’t be the only issue. Pharmacists are concerned about another FDAAA provision: the FDA’s creation of an active Sentinel adverse reaction alert system, meant to supplement its existing passive MedWatch system, which has been roundly criticized for its shortcomings. In fact, both Democrats and Republicans, often at the behest of speci...
متن کاملPharmaceutical innovation in the 21st century: new drug approvals in the first decade, 2000-2009.
The first decade of the 21st century was a challenging period for the pharma sector and could prove to be a turning point in the evolution of the industry. We examine drug development performance metrics for new product approvals during 2000-2009 and compare them with those of the prior two decades. The results indicate that, whereas total approvals are currently at a 25-year low, the percentag...
متن کامل"Breaking the bureaucracy": drug registration and neocolonial relations in Egypt.
According to the Egyptian Ministry of Health, the per capita use of prescription drugs in Egypt is amongst the highest in the world. Multinational pharmaceutical companies license their proprietary products for manufacture and sale in Egypt through their Egyptian subsidiaries. A Ministry of Health Committee reviews and approves for sale all drugs marketed in the country. Aside from being an ext...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید
ثبت ناماگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید
ورودعنوان ژورنال:
- P & T : a peer-reviewed journal for formulary management
دوره 42 6 شماره
صفحات -
تاریخ انتشار 2017